Urgently needed: a filter for the HIV-1 vaccine pipeline. Academic Article uri icon

Overview

abstract

  • Research groups worldwide are trying to make immunogens intended to elicit neutralizing antibody responses as part of a prophylactic vaccine to counter the spread of HIV-1. The relative merits of different designs can only be gauged properly through comparative studies, and particularly by evaluating human or animal antisera under identical, or comparable, conditions. Hence there is a need for assay standardization and for the creation of a centralized testing facility that could distribute consensus protocols and reagents.

publication date

  • August 1, 2004

Research

keywords

  • AIDS Vaccines
  • Acquired Immunodeficiency Syndrome
  • Drug Design
  • HIV Antibodies
  • HIV-1
  • Neutralization Tests

Identity

Scopus Document Identifier

  • 4043124699

Digital Object Identifier (DOI)

  • 10.1038/nm0804-769

PubMed ID

  • 15286768

Additional Document Info

volume

  • 10

issue

  • 8